Vol 17, No 4 (2024)
Case report
Published online: 2024-12-19
Acute kidney injury associated with anti-glomerular basement membrane (anti-GBM) antibody disease — a clinical case
DOI: 10.5603/rdatf.102803
Renal Disease and Transplantation Forum 2024;17(4):125-128.
Abstract
In differential diagnosis of causes of acute kidney
injury presenting as nephritic syndrome, several
causes should be taken into account, including diseases
associated with depositions of immune complexes,
systemic vasculitis, as well as rare causes
such as anti-glomerular basement membrane (anti-
-GBM) antibody disease. This article presents a clinical
case of a patient with this diagnosis. We present
and discuss the current standard of diagnostic
and therapeutic management, along with associated
controversies and perspectives for future therapies
for this disease.
Keywords: anti-GBMrapidly progressive glomerulonephritisGoodpasture’s syndrome
References
- McAdoo SP, Pusey CD. Anti-Glomerular Basement Membrane Disease. Clin J Am Soc Nephrol. 2017; 12(7): 1162–1172.
- Panek A, Walatek B, Sułowicz W. [Goodpasture's syndrome--disease of many faces]. Przegl Lek. 2013; 70(4): 218–223.
- Collins RD. Dr Goodpasture: "I was not aware of such a connection between lung and kidney disease". Ann Diagn Pathol. 2010; 14(3): 194–198.
- McAdoo SP, Tanna A, Hrušková Z, et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017; 92(3): 693–702.
- Kidney Disease: Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases. Kidney Int. 2021; 100(4S): S1–S276.
- Poggio ED, McClelland RL, Blank KN, et al. Kidney Precision Medicine Project. Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications. Clin J Am Soc Nephrol. 2020; 15(11): 1595–1602.
- Gulati K, McAdoo SP. Anti-Glomerular Basement Membrane Disease. Rheum Dis Clin North Am. 2018; 44(4): 651–673.
- McAdoo SP, Tanna A, Hrušková Z, et al. Patients double-seropositive for ANCA and anti-GBM antibodies have varied renal survival, frequency of relapse, and outcomes compared to single-seropositive patients. Kidney Int. 2017; 92(3): 693–702.
- Nishibata Y, Nonokawa M, Tamura Y, et al. Possible implication of intermolecular epitope spreading in the production of anti-glomerular basement membrane antibody in anti-neutrophil cytoplasmic antibody-associated vasculitis. Clin Exp Rheumatol. 2022; 40(4): 691–704.
- Rutgers A, Slot M, van Paassen P, et al. Coexistence of anti-glomerular basement membrane antibodies and myeloperoxidase-ANCAs in crescentic glomerulonephritis. Am J Kidney Dis. 2005; 46(2): 253–262.
- Reggiani F, L'Imperio V, Calatroni M, et al. Goodpasture syndrome and anti-glomerular basement membrane disease. Clin Exp Rheumatol. 2023; 41(4): 964–974.
- Uhlin F, Szpirt W, Kronbichler A, et al. Endopeptidase Cleavage of Anti-Glomerular Basement Membrane Antibodies in Severe Kidney Disease: An Open-Label Phase 2a Study. J Am Soc Nephrol. 2022; 33(4): 829–838.
- Ponticelli C, Calatroni M, Moroni G. Anti-glomerular basement membrane vasculitis. Autoimmun Rev. 2023; 22(1): 103212.
